|
Volumn 21, Issue 3, 2002, Pages 331-345
|
Sample size considerations in observational health care quality studies
|
Author keywords
Health care quality studies; Hierarchical binomial models; Sample size determination
|
Indexed keywords
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
NONSTEROID ANTIINFLAMMATORY AGENT;
ADULT;
ARTICLE;
CALCULATION;
CARDIOVASCULAR DISEASE;
CLUSTER ANALYSIS;
COHORT ANALYSIS;
CONTROLLED STUDY;
HEALTH CARE DELIVERY;
HEALTH CARE QUALITY;
HUMAN;
MAJOR CLINICAL STUDY;
OBSERVATION;
OUTCOMES RESEARCH;
RANDOMIZATION;
STANDARD;
STATISTICAL MODEL;
VALIDATION PROCESS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CLUSTER ANALYSIS;
COMPUTER SIMULATION;
HEALTH SERVICES RESEARCH;
HEART FAILURE, CONGESTIVE;
HOSPITALS, RURAL;
HOSPITALS, TEACHING;
HUMANS;
HYPERTENSION;
MODELS, STATISTICAL;
MONTE CARLO METHOD;
MYOCARDIAL INFARCTION;
QUALITY ASSURANCE, HEALTH CARE;
RESEARCH DESIGN;
SAMPLE SIZE;
|
EID: 0037083244
PISSN: 02776715
EISSN: None
Source Type: Journal
DOI: 10.1002/sim.1020 Document Type: Article |
Times cited : (33)
|
References (41)
|